# Drug-Drug Interaction Risk Screening Using Python

## Project Overview

Drug-drug interactions (DDIs) are an important concern in clinical practice, particularly when patients receive multiple medications. Manual review of medication lists can be time-consuming and may lead to missed potential interactions.

This project presents a Python-based prototype for automated DDI risk screening using structured medication data. The system identifies predefined high-risk drug combinations, assigns risk categories, and visualizes the distribution of DDI risk across the dataset.

The project was developed as an application of clinical pharmacology knowledge with Python-based data analysis.

## Objectives

- Develop a simple computational approach for screening potential drug-drug interactions.
- Identify predefined high-risk drug combinations within medication records.
- Categorize patients according to their identified DDI risk.
- Visualize the distribution of DDI risk using Python.
- Explore how computational tools could support medication review and clinical decision-making.

## Methodology

### 1. Data Preparation

A structured simulated medication dataset was created to represent patients with different medication combinations.

The dataset contains patient-level medication information that can be processed using Python and Pandas.

### 2. DDI Detection

The program compares medication combinations against predefined drug-interaction rules.

For example, combinations such as:

- Warfarin + Ciprofloxacin

are flagged as potential high-risk interactions based on the interaction rules implemented in the prototype.

### 3. Risk Stratification

Patients are categorized according to the detected interaction risk:

- **High Risk** — potentially clinically significant interaction identified
- **Medium Risk** — interaction requiring further assessment
- **None** — no predefined interaction detected

### 4. Data Visualization

Python-based visualization is used to display the distribution of DDI risk categories within the dataset.

## Technologies Used

- Python
- Pandas
- Matplotlib
- Seaborn
- Jupyter Notebook

## Example Output

The prototype generates a summary of DDI risk across the simulated patient dataset and produces visualizations showing the distribution of risk categories.

The percentage values shown in the example output represent results from the simulated dataset and should not be interpreted as findings from a real patient population.

## Clinical Relevance

The project demonstrates how basic computational approaches can be applied to medication safety problems.

A system of this type could potentially be extended to support:

- Automated medication screening
- Clinical decision-support systems
- Pharmacovigilance workflows
- DDI risk prioritization
- Integration with larger clinical datasets
- Machine-learning-based interaction prediction

## Limitations

This project is a prototype and has several limitations:

- The dataset is simulated rather than derived from real-world patient records.
- The interaction rules are predefined rather than generated through machine learning.
- The system does not replace clinical judgment or professional medication review.
- The identified interactions depend on the interaction rules implemented in the program.
- The example results cannot be generalized to real patient populations.

## Future Development

Future versions could incorporate:

- Larger real-world medication datasets
- Standardized drug identifiers
- Comprehensive DDI databases
- Severity-based interaction classification
- Patient-specific factors such as age, renal function, and comorbidities
- Machine-learning approaches for DDI prediction
- Integration with electronic health record data

## Author

**Umar Taimur Tahir**  
Doctor of Pharmacy (PharmD)  
Interested in pharmacoinformatics, computational drug safety, and AI-assisted drug discovery.
